Purple Gross Profit from 2010 to 2024

PPBT Stock

USD 4.82 1.75 26.64%

Purple Biotech Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Purple Biotech makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

-196 K

Current Value

-186.2 K

Quarterly Volatility

681.4 K

Credit Downgrade

Yuan Drop

Covid

Check Purple Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Purple Biotech's main balance sheet or income statement drivers, such as Depreciation And Amortization of 208.9 K, Interest Expense of 2.3 M or Selling General Administrative of 4.6 M, as well as many indicators such as Price To Sales Ratio of 84.89, Dividend Yield of 0.088 or PTB Ratio of 0.49. Purple financial statements analysis is a perfect complement when working with Purple Biotech Valuation or Volatility modules.

Check out the analysis of Purple Biotech Correlation against competitors.

For more information on how to buy Purple Stock please use our How to Invest in Purple Biotech guide.

Latest Purple Biotech's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Purple Biotech over the last few years. Gross profit is a required income statement account that reflects total revenue of Purple Biotech minus its cost of goods sold. It is profit before Purple Biotech operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Purple Biotech's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Purple Biotech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (120 K)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Purple Gross Profit Regression Statistics

	Arithmetic Mean	528,581
	Geometric Mean	721,166
	Coefficient Of Variation	128.90
	Mean Deviation	554,470
	Median	901,000
	Standard Deviation	681,359
	Sample Variance	464.3B
	Range	2.1M
	R-Value	(0.71)
	Mean Square Error	249.9B
	R-Squared	0.50
	Significance	0
	Slope	(107,756)
	Total Sum of Squares	6.5T

Purple Gross Profit History

	2024	-186.2 K
	2023	-196 K
	2022	-1.1 M
	2021	-551 K
	2020	765 K
	2019	999.9 K
	2018	1000 K

Other Fundumenentals of Purple Biotech

Gross Profit Margin

Purple Biotech Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Net Tangible Assets	Short Term Investments	Property Plant Equipment	Current Deferred Revenue	Net Invested Capital	Net Working Capital	Short Term Debt	Intangible Assets	Good Will
Total Assets		1.0	-0.76	-0.77	0.57	0.28	0.58	0.97	0.89	0.77	0.96	0.76	0.97	0.92	-0.75	0.85	-0.18
Total Stockholder Equity	1.0		-0.73	-0.73	0.53	0.24	0.52	0.99	0.91	0.81	0.95	0.72	0.98	0.94	-0.73	0.82	-0.15
Net Debt	-0.76	-0.73		0.88	-0.82	-0.26	-0.78	-0.69	-0.56	-0.27	-0.75	-0.66	-0.68	-0.48	0.69	-0.81	0.51
Retained Earnings	-0.77	-0.73	0.88		-0.94	-0.43	-0.95	-0.64	-0.56	-0.21	-0.83	-0.79	-0.73	-0.48	0.83	-0.9	0.64
Accounts Payable	0.57	0.53	-0.82	-0.94		0.38	0.93	0.43	0.43	-0.01	0.69	0.68	0.56	0.25	-0.74	0.82	-0.82
Net Receivables	0.28	0.24	-0.26	-0.43	0.38		0.45	0.21	-0.07	-0.09	0.29	0.65	0.18	0.12	-0.66	0.18	-0.12
Total Liab	0.58	0.52	-0.78	-0.95	0.93	0.45		0.43	0.34	-0.05	0.66	0.66	0.54	0.25	-0.71	0.78	-0.75
Total Current Assets	0.97	0.99	-0.69	-0.64	0.43	0.21	0.43		0.89	0.85	0.89	0.65	0.96	0.96	-0.66	0.73	-0.08
Net Tangible Assets	0.89	0.91	-0.56	-0.56	0.43	-0.07	0.34	0.89		0.86	0.89	0.52	0.94	0.91	-0.52	0.79	-0.17
Short Term Investments	0.77	0.81	-0.27	-0.21	-0.01	-0.09	-0.05	0.85	0.86		0.68	0.34	0.81	0.95	-0.32	0.45	0.29
Property Plant Equipment	0.96	0.95	-0.75	-0.83	0.69	0.29	0.66	0.89	0.89	0.68		0.8	0.95	0.85	-0.79	0.94	-0.29
Current Deferred Revenue	0.76	0.72	-0.66	-0.79	0.68	0.65	0.66	0.65	0.52	0.34	0.8		0.69	0.58	-0.98	0.74	-0.24
Net Invested Capital	0.97	0.98	-0.68	-0.73	0.56	0.18	0.54	0.96	0.94	0.81	0.95	0.69		0.94	-0.71	0.84	-0.24
Net Working Capital	0.92	0.94	-0.48	-0.48	0.25	0.12	0.25	0.96	0.91	0.95	0.85	0.58	0.94		-0.57	0.65	0.09
Short Term Debt	-0.75	-0.73	0.69	0.83	-0.74	-0.66	-0.71	-0.66	-0.52	-0.32	-0.79	-0.98	-0.71	-0.57		-0.72	0.35
Intangible Assets	0.85	0.82	-0.81	-0.9	0.82	0.18	0.78	0.73	0.79	0.45	0.94	0.74	0.84	0.65	-0.72		-0.47
Good Will	-0.18	-0.15	0.51	0.64	-0.82	-0.12	-0.75	-0.08	-0.17	0.29	-0.29	-0.24	-0.24	0.09	0.35	-0.47

Click cells to compare fundamentals

About Purple Biotech Financial Statements

Purple Biotech shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Purple Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Purple Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Purple Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Gross Profit	-196 K	-186.2 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC